Mouwasat Medical Services Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Mouwasat Medical Services Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR 153Over the last 3 years, every SAR 100 of reported profit came with SAR 153 of operating cash.
Higher than 62% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
2.8×Over the last 3 years its own operating cash covered its investment spending (capex) 2.8 times.
Higher than 54% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 23For every SAR 100 of sales, SAR 23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 45 tied up three years earlier.
Less money tied up than 71% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Less steady than 67% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 25Sales grew 38% in 3 years; of every extra SAR 100 of sales, SAR 25 became extra profit.
Higher than 79% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+38% / +28%In 3 years sales changed by +38% while total assets changed by +28%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
6.2×Debt due within a year is covered 6.2 times by its yearly operating cash.
Higher than 71% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Higher than 79% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
99%Of every SAR 100 the company owns, SAR 99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 77% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
99%Of every SAR 100 of net worth, SAR 99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 77% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Mouwasat Medical Services Company owes SAR 0.38 for every SAR 1 it owns. Net profit rose 27% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
13.0Investors pay SAR 13.0 for every SAR 1 of Mouwasat Medical Services Company's yearly profit, lower than 96% of Healthcare companies in Saudi Arabia.
P/B ratio
2.80The share price is 2.80 times Mouwasat Medical Services Company's book value per share, higher than 71% of Healthcare companies in Saudi Arabia.
Market cap
SAR 11.1 BThe total market value of all of Mouwasat Medical Services Company's shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Net worth (book value)
SAR 4.0 BWhat Mouwasat Medical Services Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 19.83Net worth divided by the number of shares. The share price of SAR 55.45 is 2.8 times this, which is the P/B above.
Return on equity (ROE)
22.6%Mouwasat Medical Services Company earned 22.6% on its shareholders' money over the last year, higher than 68% of Healthcare companies in Saudi Arabia.
Owes vs Owns
0.38×Mouwasat Medical Services Company owes SAR 0.38 for every SAR 1 it owns (low), lower than 79% of Healthcare companies in Saudi Arabia.
Dividend yield
3.98%Mouwasat Medical Services Company pays 3.98% of its share price as dividends a year, higher than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+12%Revenue rose 12% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Profit growth
+27%Net profit rose 27% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Profit margin
25.5%Mouwasat Medical Services Company keeps SAR 26 of every SAR 100 of revenue as net profit.
Cash quality
1.4×Cash from Mouwasat Medical Services Company's business was 1.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
44.5×Mouwasat Medical Services Company's operating profit covered its interest costs 44.5 times in the year to Dec 2025.
Cash vs debt
Net debtMouwasat Medical Services Company had SAR 492 M more debt than cash (net debt) at Dec 2025.
Questions
What is Mouwasat Medical Services Company's P/E ratio?
Investors pay SAR 13.0 for every SAR 1 of Mouwasat Medical Services Company's yearly profit, lower than 96% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Mouwasat Medical Services Company: SAR 11.1 B ÷ SAR 4.0 B (30 Jun 2026) = 2.8.
What is Mouwasat Medical Services Company's return on equity?
Mouwasat Medical Services Company earned 22.6% on its shareholders' money over the last year, higher than 68% of Healthcare companies in Saudi Arabia.
How much does Mouwasat Medical Services Company owe compared with what it owns?
Mouwasat Medical Services Company owes SAR 0.38 for every SAR 1 it owns (low), lower than 79% of Healthcare companies in Saudi Arabia.
Does Mouwasat Medical Services Company pay a dividend?
Yes. Mouwasat Medical Services Company pays 3.98% of its share price as dividends a year, higher than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Is Mouwasat Medical Services Company's revenue growing?
Revenue rose 12% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.